Introduction: Laparoscopic (Lap) surgery has not been established as a standard
Introduction
Laparoscopic (Lap) resection has become a popular option for surgical treatment of colon cancers. Large randomized clinical trials have demonstrated the short-term benefits of Lap colectomy compared with open colectomy-reduced postoperative pain, faster recovery of bowel movement, and shorter hospital stay-as well as the feasibility and safety of the approach (1) (2) (3) (4) . In addition, long-term oncological outcomes are comparable between Lap and open procedures (4) (5) (6) . However, in the case of locally advanced colon cancer with suspected involvement of adjacent organs (T4b), it is sometimes technically demanding to complete en-bloc resection of adjacent structures invaded by a tumor with an adequate surgical margin under laparoscopy. Therefore, T4 tumor has been an exclusion criterion in major randomized clinical trials (2) (3) (4) 7) .
Multivisceral resection (MVR) has been known to increase the risk of postoperative morbidity in open colectomy (8) (9) (10) . In the Colon Cancer Laparoscopic or Open Resection (COLOR) trial, conversion to open procedure was most frequent in T4 patients (2) . Lap MVR is generally not indicated in major guidelines. The European Association of Endoscopic Surgery consensus, the Society of American Gastrointestinal and Endoscopic Surgeons recommendation, the US National Comprehensive Cancer Network guidelines, and the French guidelines state that MVR should be performed by the open technique (11) (12) (13) (14) .
Significant advances have been made in the Lap technique in the last decade (15, 16) , and several studies have reported the safety and feasibility of Lap MVR, although the evidence is insufficient at present. As such, the indications for Lap MVR in T4b patients are still under debate.
In this study, we used the database of a single institution and retrospectively evaluated the safety and oncological feasibility of Lap MVR for T4b colon cancers.
Materials and Methods
This study was a retrospective chart review that was approved by ethics committee, Kyoto University Graduate School and Faculty of Medicine (approval no. R0871). All consecutive patients who underwent surgical resection of colonic adenocarcinoma with the aim of complete removal of the primary tumor between June 2005 and December 2014 in our department were identified from the institutional database. All participants gave informed consent before their inclusion in the study. Rectal cancer and surgery for recurrent cancer were excluded. Surgical T4b (sT4b) patients were further extracted for analyses. Both elective and emergent operations, as well as resection of primary tumor in patients with distant metastases, were included in this study. Patients in whom T4b disease was not suspected in preoperative assessment and who were first diagnosed during surgery (non-cT4b) were included in the study. Among the 88 patients identified based on these criteria, 4 were excluded from the analyses because they underwent synchronous surgery for other diseases (primary gastric cancer, primary esophageal cancer, metastatic liver cancer, and pseudomyxoma peritonei). Ultimately, 84 patients (Lap, 48; open, 36) were included for analysis. When invasion was found in two or more organs, the affected organ that influenced the decision on the operative approach was considered in the analysis. Cases of conversion from laparoscopy to the open approach were classified into the Lap group based on the intention-to-treat principleunless otherwiseindicated.None of the patients underwent hand-assisted or robotic surgery in the Lap group.
All patients underwent preoperative evaluation of tumor depth or adjacent organ invasion involving total colonoscopy (unless obstruction was present) and CT. The results were routinely discussed in a multidisciplinary meeting before initiation of treatment. Comorbidity was defined as the presence of at least one of the following diseases: hypertension, hyperlipidemia, diabetes mellitus, coronary artery disease, arrhythmia, chronic occlusive pulmonary disease, bronchial asthma, and chronic kidney disease.
The operative approach for MVR was determined at the preoperative planning meeting. Discussions took into consideration several factors such as tumor size, involvement of adjacent organs, extent of invasion, history of previous laparotomy, patient's body shape, and estimated length of skin incision for specimen retrieval. Finally, we decided on the more advantageous approach to ensure the patient's safety and to achieve complete tumor clearance (R0) for each individual case.
The operative procedures were as follows. Radical resection of the tumor-bearing segment with lymph node dissection was performed by high ligation of vessels according to the lymphatic drainage. Involved adjacent structures were resected en bloc with an adequate surgical margin. In the Lap group, the specimen was retrieved by minimally extending the umbilical wound through the wound protector. Conversion was defined as unplanned laparotomy. Postoperative morbidity was defined as the presence of at least one of following complications which was classified as ClavienDindo grade 2 or higher: wound infection, anastomotic leakage, peritoneal abscess, ileus, neurogenic bladder, and pneumonia. R1 was defined as microscopic presence of tumor at the resection margin of the specimen.
For postoperative follow-up, pStage III or IV patients consulted oncologists for chemotherapy. Patients were followed up regularly as outlined by national guidelines. When any suspicious finding was detected, the patient underwent closer follow-up or further investigation.
All statistical analyses were performed by JMP Pro software v. 11.0.0 (SAS Institute, Cary, USA). Categorical variables were expressed as frequency and proportion (%), and numerical data as means and ranges, unless otherwise indicated. χ 2 tests, the Mann-Whitney U-test, and
Fischer's exact test were performed to compare independent groups when appropriate. Kaplan-Meier curves were created to assess overall survival (OS) and disease-free survival (DFS), and significant differences in survival times between the patient subgroups were analyzed using log-rank tests. Univariate and multivariate analyses based on logistic regression were used to identify significant factors affecting OS or DFS. A P-value less than 0.05 was considered statistically significant.
Results

Demographics and clinical features of sT4b patients
A total of 812 patients underwent surgical resection for colon cancer during the study period. Eighty-four patients (10.3%) had been diagnosed with sT4b disease and satisfied the inclusion criteria. Table 1 . Age, sex, BMI, comorbidity, history of laparotomy, and tumor location and stage were comparable between the two groups. The open procedure was more commonly chosen for patients who were preoperatively estimated to be T4b (P < 0.001). Performance status was better in the Lap group (performance status ≥1: 22.9% vs 44.4%, P = 0.037). A greater proportion of patients in the open group received neoadjuvant chemotherapy (6.3% vs 25.0%, P = 0.015). Tumor diameters were significantly greater in the open group (60 mm vs 71 mm, P = 0.001). pT4b was confirmed in 55.6% and 45.8% of patients in the open and Lap groups, respectively.
Lap completion
The involved adjacent structures and operative approach are listed in Table 2 . We categorized the invaded organ into two groups. Subgroup A comprises organs that do not directly influence homeostasis-namely, the abdominal wall, small or large intestine, mesentery, retroperitoneum (except the ureters), and the uterus or ovaries. Subgroup B consists of urinary tract organs (ureters and the bladder), injury to which might significantly harm the patient's quality of life. When invasion was found at the subgroup A organs, Lap resection was successfully completed in the majority of cases, even in the cases of non-cT4b; the conversion rate was 9.5% (4/42). In subgroup B, although the Lap approach was selected for only 5 of 16 cases under careful preoperative consideration, completion was challenging, and the conversion rate was higher at 40.0% (2/5). Lap resection was completed in three patients with bladder invasion, but two patients with ureteral involvement surgery required conversion. Within subgroup A, the diameters of tumors were smaller in patients who achieved Lap completion than in those who had open or conversion surgery (P < 0.001). Conversely, tumor diameters were similar in subgroup B (P = 0.587). This discrepancy could indicate that Lap enbloc resection followed by reconstruction of the urinary tract is technically challenging, irrespective of tumor size. Indeed, in our experience, Lap completion may also be influenced by the need for reconstruction after MVR. Among the patients in the Lap group who did not require reconstruction, resection was achieved laparoscopically in 36 of 39. Similarly, intestinal reconstruction did not result in conversion. In contrast, laparoscopic reconstruction was completed in only a few of the 12 patients with urinary tract invasion. Only one patient with bladder invasion underwent Lap primary closure after combined partial resection of the dome of the bladder. Two cases with ureter involvement were converted to open surgery. The other nine patients underwent open surgery from the outset (Figure 2 ).
Short-term outcomes
As shown in Table 3 , analyses of perioperative short-term outcomes revealed that the Lap procedure was superior to the open procedure in terms of intraoperative blood loss (57.5 mL vs 321.0 mL, P = 0.000), morbidity (16.7% vs 36.1%, P = 0.042), and postoperative hospital stay (14.0 days vs 22.5 days, P = 0.001). Mortality within 30 days after surgery was 0% in both groups. R1 was identified in two patients in the Lap group, but both had multiple distant metastases and underwent palliative surgeries for bowel obstruction.
Regarding the six conversion cases, the reasons for conversion were invasion of the abdominal wall (n = 2), adjacent small intestine (n = 1) or ureter (n = 2), and bleeding from the accessory right colic vein (n = 1). When compared with the Lap completion group, the conversion group had worse outcomes in terms of duration of the operation (325 min vs 279 min), blood loss (366.0 mL vs 49.5 mL), need for blood transfusion (16.7% vs 2.4%), and morbidity (33.3% vs 14.3%), although these differences were not statistically significant because of the small sample size. Lap resection for T4b colon cancers R Takahashi et al.
However, the morbidity rate in the conversion group (2/6, 33.3%) was similar to that in the open group (36.1%). In addition, these two patients had complications of grade 2 paralytic ileus, which resolved without nasogastric tube insertion or total parenteral nutrition. These results suggest that conversion was not strongly associated with an elevated risk of severe complications when compared with open surgery in this study. None of the patients in the conversion group was found to be R1.
Long-term outcomes
Twenty-one stage IV patients were excluded, and 63 patients with stage II/III were analyzed. The median follow-up period was 48.4 months for all 63 patients, and 56.9, 40.3, and 66.7 months for the Lap completion, open, and conversion groups, respectively. Kaplan-Meier survival curves revealed no significant difference in OS (P = 0.441) or DFS (P = 0.846) between the groups (Figure 3) . The 3-year survival rates were 92.8%, 79.8%, and 100% in the Lap completion, open, and conversion groups, respectively. Univariate analyses showed that OS was shorter in male patients (P = 0.007). Also, DFS was worse in male patients (P = 0.002) and pStage III patients (P = 0.017). The operative approach had no significant effect on OS or DFS. Multivariate analyses also confirmed that the operative approach did not affect the patients' OS or DFS (Table 4) 
Discussion
Significant advances in Lap techniques and devices have been made, and the magnified view provided by laparoscopy enables us to identify an adequate dissection plane Lap resection for T4b colon cancers R Takahashi et al.
and to perform fine operative procedures in colon cancer surgery. The Lap approach has gradually been adopted for the treatment of early cancers and more advanced disease, but the indications for the procedure in T4 cancers remain controversial, despite having been discussed extensively. Several studies, including one by Nakafusa et al., reported that MVR is associated with higher postoperative morbidity (8) (9) (10) 17) . Increased risk of conversion in T4 cancers has also been reported. In the COLOR trial, although the overall conversion rate was 17%, the rate was 50% (15/30) in T4 patients (2) . In contrast, other studies demonstrated satisfactory outcomes in T4 cancers (14, (18) (19) (20) (21) (22) . For example, Shukla et al. retrospectively investigated the short-and long-term outcomes of 83 patients with T4 cancer and concluded that the Lap approach was a feasible option for T4 cancers (14) . Other groups have also reported the safety and feasibility of Lap MVR (20, 22) .
In our study, Lap MVR was well completed when reconstruction was not required. However, when urinary tract invasion is possible, the indication for Lap MVR should be carefully considered, although few reports have discussed this issue. Reconstruction of the ureter requires the skill of extensively trained surgeons, and complications affecting this vital organ would severely threaten postoperative outcome and quality of life. In our experience, so far, Lap resection could not be completed in any of the patients with ureteral involvement. Vignali et al. also reported a case of ureteral invasion, which resulted in conversion (21). Gezen et al. resected the involved ureter separately for a technical reason (23) . At present, we believe that patients with ureteral involvement are not good candidates for Lap MVR because the technical difficulty and risk of complications outweigh the benefits. Nevertheless, we recognize that Lap reconstruction of the urinary tract after total prostatectomy has become a well-established procedure among urologists with accumulated experience, especially with the emergence of robotic surgery. Therefore, this argument, at least to some extent, depends on the experience and technique of urologists at each institution. The perioperative outcomes were significantly better in the Lap group in terms of intraoperative blood loss, morbidity, and postoperative hospital stay. In the conversion group, several intraoperative outcomes and the morbidity rate were worse than in the Lap group, but they were almost comparable with those in the open group. Several studies have reported that conversion to laparotomy is associated with worse perioperative outcomes such as increased morbidity and mortality, and adverse long-term oncological outcomes have also been suspected (24, 25) . However, conversion has more recently been categorized into two subtypes: (i) strategic conversion, which is a preemptive decision to avoid complications; and (ii) reactive conversion, which is the need to perform laparotomy because of unanticipated operative difficulty or complications (26, 27) . Strategic conversion is known to be associated with better outcomes than reactive conversion (27) . In this study, excluding the conversion case that was reactive due to bleeding, the remaining five conversion cases were strategic. Indeed, postoperative morbidities (grade-2 paralytic ileus) were relatively minor, the patients' hospital stays were not extended, and long-term outcomes were satisfactory. This possibly indicates that well-considered conversion to avoid unexpected intraoperative events may have no significant adverse effects on short-and long-term outcomes.
Another concern is the risk of R1 resection-that is, insufficient clearance of cancer tissue. Achieving R0 resection is essential for curing cancer in T4 patients, and it is the most important factor influencing long-term outcomes after MVR (10, 28) . It has been argued that achievement of R0 might be threatened by choosing the Lap approach (21) , and the COLOR trial detected a microscopic positive margin (R1) in 20% of T4 patients, compared with only 1% of T3 patients (2) . However, the open group in the COLOR trial showed little advantage regarding this point (T4, 17.6%; T3, 1.0%). As such, the risk of R1 resection when using the Lap approach for T4 tumors has not been fully confirmed. In the present study, the R1 rate was not increased in the Lap group, and the two cases of R1 resection in the Lap group were performed for palliation for stage IV patients. Thus, R1 had no adverse impact on the clinical course.
According to the database of the Japanese Society for Cancer of the Colon and Rectum, the 5-year survival rates of stage II colorectal cancer and stage III colon cancer (including both simple resection and MVR) were 81% and 69%, respectively (29) . In our MVR analyses, the 5-year survival rates of the Lap completion group and conversion group were comparable (87.1% and 100%, respectively), although the duration of follow-up was insufficient.
In summary, the conversion rate, R1 rate, and short-and long-term outcomes in this study were encouraging. Strategic conversion was not associated with severe morbidity, and it had no adverse effect on long-term oncological outcomes. Therefore, the Lap approach should be considered for sT4b cancers in appropriately selected patients. As in several previous studies, the limitations of this study include the retrospective nature of the study, the fact that it was performed at a single institution, the small sample size, and the relatively short follow-up period. Selection bias is inevitable in this study design, and all surgeries were performed by technically matured team. Therefore, the indications for Lap approach should be carefully considered in each institution according to skill and experience. The same issue should be discussed with respect to rectal cancer, and this will be investigated in a future study. We anticipate that further accumulation of evidence will make the Lap approach a popular procedure for locally advanced colon cancers. As the magnified view of laparoscopy is fully utilized and the technique of surgeons improves, we expect the fine dissection afforded by Lap surgery to achieve better outcomes than conventional open surgery in the near future.
In conclusion, Lap MVR for sT4b colon cancers is a safe and feasible option, except in cases that require complicated reconstruction of the urinary tract.
